We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ZLDPF market cap is 6.92B. The company's latest EPS is DKK -13.7224 and P/E is -9.84.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 41.78M | 390.31M | 293.33M | 191.6M | 358.77M |
| Operating Income | -587.94M | -792.36M | -1.05B | -1.06B | -572.24M |
| Net Income | -571.54M | -846.73M | -1.02B | -1.2B | -703.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 1.6B | 1.76B | 2.07B | 1.54B | 1.98B |
| Total Liabilities | 356.84M | 532.64M | 1.14B | 723.9M | 387.15M |
| Total Equity | 1.24B | 1.23B | 927.8M | 815.91M | 1.59B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | -409.46M | -688.72M | -1.21B | -942.21M | -425.67M |
| Investing | -51.67M | -196.81M | -18.12M | 281.26M | -1.09B |
| Financing | 674.48M | 760.94M | 1.33B | 587.4M | 907.01M |
| Market Cap | 6.92B |
| Price to Earnings Ratio | -9.84 |
| Price to Sales Ratio | 19.3 |
| Price to Cash Ratio | 15.41 |
| Price to Book Ratio | 4.35 |
| Dividend Yield | - |
| Shares Outstanding | 51.28M |
| Average Volume (1 week) | 1.98k |
| Average Volume (1 Month) | 4.2k |
| 52 Week Change | 273.44% |
| 52 Week High | 140.28 |
| 52 Week Low | 33.42 |
| Spread (Intraday) | 4.46 (3.26%) |
| Company Name | Zealand Pharma AS (PK) |
| Address |
sydmarken 11 soborg DK-2600 |
| Website | https://www.zealandpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
